Induction Healthcare Group PLC
LSE:INHC
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Induction Healthcare Group PLC
Induction Healthcare Group PLC
Cost of Revenue
Induction Healthcare Group PLC
Cost of Revenue Peer Comparison
RENX
CRW
IUG
INS
EMIS
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Induction Healthcare Group PLC
LSE:INHC
|
Cost of Revenue
-£4.8m
|
CAGR 3-Years
-302%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Renalytix PLC
LSE:RENX
|
Cost of Revenue
-$2.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Craneware PLC
LSE:CRW
|
Cost of Revenue
-$26.3m
|
CAGR 3-Years
-68%
|
CAGR 5-Years
-45%
|
CAGR 10-Years
-27%
|
|
|
Intelligent Ultrasound Group PLC
LSE:IUG
|
Cost of Revenue
-£4.3m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
Instem PLC
LSE:INS
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
EMIS Group PLC
LSE:EMIS
|
Cost of Revenue
-£10.9m
|
CAGR 3-Years
18%
|
CAGR 5-Years
6%
|
CAGR 10-Years
0%
|
See Also
What is Induction Healthcare Group PLC's Cost of Revenue?
Cost of Revenue
-4.8m
GBP
Based on the financial report for Mar 31, 2023, Induction Healthcare Group PLC's Cost of Revenue amounts to -4.8m GBP.
What is Induction Healthcare Group PLC's Cost of Revenue growth rate?
Cost of Revenue CAGR 3Y
-302%
Over the last year, the Cost of Revenue growth was -73%. The average annual Cost of Revenue growth rates for Induction Healthcare Group PLC have been -302% over the past three years .
You don't have any saved screeners yet
